Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil and Rebound Pain in Shoulder Arthroplasty
NCT04236323Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2020
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, triple-blind trial of remifentanil in postoperative pain, sponsored by Seoul National University Hospital. Primary endpoint: Total infused dose of patient controlled analgesia drug at 24 hours. Started Feb 2020; status: completed.
02
Drugs
remifentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04236323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04236323.